pyridoxine has been researched along with Glycogen Storage Disease Type V in 5 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Glycogen Storage Disease Type V: Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.
| Excerpt | Relevance | Reference |
|---|---|---|
| "McArdle's disease is defined as a lack of functional muscle glycogen phosphorylase." | 1.29 | McArdle's disease: molecular genetics and metabolic consequences of the phenotype. ( Bartram, C; Beynon, RJ; Edwards, RH; Gibson, H; Hopkins, P; Phoenix, J; Toescu, V, 1995) |
| "Pyridoxal phosphate is a covalently bound cofactor of glycogen phosphorylase." | 1.27 | Low muscle levels of pyridoxine in McArdle's syndrome. ( Cook, JD; Dempsey, WB; Feit, H; Haller, RG; Knochel, JP, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haller, RG | 2 |
| Dempsey, WB | 1 |
| Feit, H | 1 |
| Cook, JD | 1 |
| Knochel, JP | 1 |
| Beynon, RJ | 3 |
| Bartram, C | 3 |
| Hopkins, P | 3 |
| Toescu, V | 2 |
| Gibson, H | 1 |
| Phoenix, J | 3 |
| Edwards, RH | 3 |
| Flannery, A | 1 |
| Evershed, RP | 1 |
| Leyland, D | 1 |
| Quinlivan, RC | 1 |
1 review available for pyridoxine and Glycogen Storage Disease Type V
| Article | Year |
|---|---|
Interrelationships between metabolism of glycogen phosphorylase and pyridoxal phosphate--implications in McArdle's disease.
Topics: Animals; Glycogen Storage Disease Type V; Humans; Isotope Labeling; Models, Biological; Muscles; Pho | 1996 |
4 other studies available for pyridoxine and Glycogen Storage Disease Type V
| Article | Year |
|---|---|
Low muscle levels of pyridoxine in McArdle's syndrome.
Topics: Adolescent; Adult; Animals; Female; Glycogen Storage Disease; Glycogen Storage Disease Type V; Human | 1983 |
McArdle's disease: molecular genetics and metabolic consequences of the phenotype.
Topics: Base Sequence; Exercise; Fatigue; Glycogen Storage Disease Type V; Humans; Molecular Sequence Data; | 1995 |
Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study.
Topics: Dietary Supplements; Exercise; Glycogen Storage Disease Type V; Humans; Male; Middle Aged; Muscle Cr | 1998 |
Treatment of McArdle disease.
Topics: Creatine; Diet Therapy; Energy Metabolism; Exercise Tolerance; Glycogen Storage Disease Type V; Huma | 2000 |